The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
|Articles|May 27, 2022
News Roundup: May 23 to May 27
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Examining the Professional Landscape for Pharmacy Techs
The scope of practice for pharmacy techs has changed in recent years, allowing for greater responsibilities, and the current labor shortage poses some challenges.
New Formulation Approval Patterns Indicate “Evergreening” by Drugmakers
Findings in show that new formulations were more likely for blockbuster drugs and drugs that received accelerated approval. Proxy measures of clinical usefulness and other elements of therapeutic value were not associated with new formulations.
Favorable Response to Third Dose of Pfizer-BioNTech Vaccine Noted for Kids 6 Months to 5 Years
Pfizer-BioNTech reports strong immune response, high efficacy, and favorable safety in third dose of the COVID-19 vaccine.
Examining the Impact of Sleep Deprivation in Eye Disease
Researchers may have identified a potential solution.
Antibiotics Linked to Higher IBD Risk in Older Adults
Seniors prescribed multiple courses of antibiotics were at greater risk for IBD.
Advertisement
Related to this article
The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.
Through the ACCESS program, Mark Ey, RPh, notes that pharmacies can now start billing for a variety of services they’ve already been providing.
The medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.
In part 3, Rebold explores improving the ART formulary protocol through introducing pharmacist-led transition-of-care services.
Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
A new option for adults who have experienced stroke will now be available to further reduce future risk.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Adds NAION Eye Risk Warning to All GLP-1 Labels
2
The Pharmacy Model Creating New Billing Pathways, Improved Recognition
3
New Report Finds Pharmacies Key in Long-Term GLP-1 Success
4
Vaxcyte’s VAX-31 Pneumococcal Vaccine Meets All Phase 3 Primary Goals
5